research 572 Development of immunotherapies targeting TCR-Vβ2 for treatment of cutaneous T cell lymphoma
Targeting TCR-Vβ2 in cutaneous T cell lymphoma shows promise for safer, more specific treatment.
Hisar, Haryana, India
Kurnool, Andhra Pradesh, India
Montes Claros, MG, Brazil
Liverpool, United Kingdom
Buenos Aires, BA, Argentina
Bragança Paulista, SP, Brazil